Simpler Grants.gov #PAR-25-184

NIH Grant for Early Stage Testing of Pharmacologic or Device-based Interventions for Mental Disorders

This opportunity from the National Institutes of Health (NIH), via the National Institute of Mental Health (NIMH), seeks applications for early stage testing of pharmacologic or device-based interventions for mental disorders. - Government Buyer: - National Institutes of Health (NIH) - National Institute of Mental Health (NIMH) - Products/Services Requested: - Early stage clinical testing of pharmacologic interventions - Early stage clinical testing of neuromodulatory device-based interventions - Focus on interventions with novel mechanisms of action - Protocols must test the presumed mechanism of action and provide data on target modulation effects - OEMs and Vendors: - No specific OEMs or vendors are named in this solicitation - Unique or Notable Requirements: - Experimental therapeutics approach is required - Clinical trials must evaluate both clinical effects and underlying mechanisms - Open to a wide range of applicants, including government entities, businesses, nonprofits, educational institutions, tribal governments, faith-based organizations, and foreign entities - No specific products, part numbers, or purchase quantities are identified

Description

This funding opportunity from the National Institutes of Health supports early stage testing of pharmacologic or device-based interventions for mental disorders. The focus is on interventions with novel mechanisms of action, using protocol designs that test the presumed mechanism of action to provide meaningful information on target modulation effects. The goal is to evaluate both the clinical effect and underlying mechanisms of the interventions. Eligible applicants include a wide range of government entities, businesses, nonprofits, and educational institutions.

View original listing